Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Bioanalytical Testing Services Market, By Molecule Type
7.1. Bioanalytical Testing Services Market, By Molecule Type, 2020-2030
7.1.1. Small Molecule
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Large Molecule
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Others
7.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Bioanalytical Testing Services Market, By Test Type
8.1. Bioanalytical Testing Services Market, By Test Type, 2020-2030
8.1.1. ADME
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. PK
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. PD
8.1.3.1. Market Revenue and Forecast (2016-2030)
8.1.4. Bioavailability
8.1.4.1. Market Revenue and Forecast (2016-2030)
8.1.5. Bioequivalence
8.1.5.1. Market Revenue and Forecast (2016-2030)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Bioanalytical Testing Services Market, By WorkFlow
9.1. Bioanalytical Testing Services Market, By WorkFlow, 2020-2030
9.1.1. Sample Preparation
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Sample Analysis
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Other Processes
9.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Bioanalytical Testing Services Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, By Molecule Type (2016-2030)
10.1.2. Market Revenue and Forecast, By Test Type (2016-2030)
10.1.3. Market Revenue and Forecast, By WorkFlow (2016-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, By Molecule Type (2016-2030)
10.1.4.2. Market Revenue and Forecast, By Test Type (2016-2030)
10.1.4.3. Market Revenue and Forecast, By WorkFlow (2016-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, By Molecule Type (2016-2030)
10.1.5.2. Market Revenue and Forecast, By Test Type (2016-2030)
10.1.5.3. Market Revenue and Forecast, By WorkFlow (2016-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, By Molecule Type (2016-2030)
10.2.2. Market Revenue and Forecast, By Test Type (2016-2030)
10.2.3. Market Revenue and Forecast, By WorkFlow (2016-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, By Molecule Type (2016-2030)
10.2.4.2. Market Revenue and Forecast, By Test Type (2016-2030)
10.2.4.3. Market Revenue and Forecast, By WorkFlow (2016-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, By Molecule Type (2016-2030)
10.2.5.2. Market Revenue and Forecast, By Test Type (2016-2030)
10.2.5.3. Market Revenue and Forecast, By WorkFlow (2016-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, By Molecule Type (2016-2030)
10.2.6.2. Market Revenue and Forecast, By Test Type (2016-2030)
10.2.6.3. Market Revenue and Forecast, By WorkFlow (2016-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, By Molecule Type (2016-2030)
10.2.7.2. Market Revenue and Forecast, By Test Type (2016-2030)
10.2.7.3. Market Revenue and Forecast, By WorkFlow (2016-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, By Molecule Type (2016-2030)
10.3.2. Market Revenue and Forecast, By Test Type (2016-2030)
10.3.3. Market Revenue and Forecast, By WorkFlow (2016-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, By Molecule Type (2016-2030)
10.3.4.2. Market Revenue and Forecast, By Test Type (2016-2030)
10.3.4.3. Market Revenue and Forecast, By WorkFlow (2016-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, By Molecule Type (2016-2030)
10.3.5.2. Market Revenue and Forecast, By Test Type (2016-2030)
10.3.5.3. Market Revenue and Forecast, By WorkFlow (2016-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, By Molecule Type (2016-2030)
10.3.6.2. Market Revenue and Forecast, By Test Type (2016-2030)
10.3.6.3. Market Revenue and Forecast, By WorkFlow (2016-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, By Molecule Type (2016-2030)
10.3.7.2. Market Revenue and Forecast, By Test Type (2016-2030)
10.3.7.3. Market Revenue and Forecast, By WorkFlow (2016-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, By Molecule Type (2016-2030)
10.4.2. Market Revenue and Forecast, By Test Type (2016-2030)
10.4.3. Market Revenue and Forecast, By WorkFlow (2016-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, By Molecule Type (2016-2030)
10.4.4.2. Market Revenue and Forecast, By Test Type (2016-2030)
10.4.4.3. Market Revenue and Forecast, By WorkFlow (2016-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, By Molecule Type (2016-2030)
10.4.5.2. Market Revenue and Forecast, By Test Type (2016-2030)
10.4.5.3. Market Revenue and Forecast, By WorkFlow (2016-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, By Molecule Type (2016-2030)
10.4.6.2. Market Revenue and Forecast, By Test Type (2016-2030)
10.4.6.3. Market Revenue and Forecast, By WorkFlow (2016-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, By Molecule Type (2016-2030)
10.4.7.2. Market Revenue and Forecast, By Test Type (2016-2030)
10.4.7.3. Market Revenue and Forecast, By WorkFlow (2016-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, By Molecule Type (2016-2030)
10.5.2. Market Revenue and Forecast, By Test Type (2016-2030)
10.5.3. Market Revenue and Forecast, By WorkFlow (2016-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, By Molecule Type (2016-2030)
10.5.4.2. Market Revenue and Forecast, By Test Type (2016-2030)
10.5.4.3. Market Revenue and Forecast, By WorkFlow (2016-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, By Molecule Type (2016-2030)
10.5.5.2. Market Revenue and Forecast, By Test Type (2016-2030)
10.5.5.3. Market Revenue and Forecast, By WorkFlow (2016-2030)
Chapter 11. Company Profiles
11.1. PPD
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. ICON plc
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Covance Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. LabCorp
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Charles River Laboratories International, Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. inVentiv Health
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. SGS SA
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Toxikon, Inc
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Intertek group
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Pace Analytical Services, LLC
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms